Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 522
Selected: 0
NCT IDTitle
NCT05193149Inspiratory Muscle Training in Obese Breast Cancer Survivors
NCT07594678Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
NCT07095140Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults
NCT03039140Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors
NCT00201669A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
NCT05349227Comprehensive Outcomes for After Cancer Health
NCT00061906Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
NCT02122081Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT07447700A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer
NCT05428852Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
NCT02518555Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT02193568Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy
NCT06305884Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study
NCT06523556Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
NCT00201760Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
NCT07215988Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
NCT07249346Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
NCT03892044Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
NCT05716477Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients
NCT04229381Resiliency Among Older Adults Receiving Lung Cancer Treatment
NCT06964737Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
NCT04640259Epidemiology of Young Lung Cancer - Survey
NCT01478477Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
NCT05503251Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
NCT06031194Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma
NCT04454086Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors
NCT03943342Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
NCT06644664Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
NCT06249984Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
NCT01696760Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
NCT06330805Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT00201773Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
NCT03513562Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT04919369All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT01644955Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
NCT07455513A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
NCT02512497Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
NCT01801059Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer
NCT07423585Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
NCT00428922Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
NCT04781088Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT05453773Hookah Additive Research to Inform Product Standards
NCT05236894Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population
NCT05243069Head and Neck Cancer Patient Symptom and Oncologic Outcomes
NCT02072356Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
NCT03102866Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer
NCT00624936Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
NCT04956302Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06203912Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma